将实施科学纳入心血管疾病的脆弱性干预
Kang Hui Teow1, Jie Jun Wong1, Yang Zhao2
1Department of Cardiology, National Heart Centre Singapore, Singapore.
JACC. Advances
|December 5, 2025
概括
实施科学是解决心血管疾病患者脆弱性的关键. 将脆弱性干预整合到常规护理中,需要了解临床试验中的实施障碍和促进者.
科学领域:
- 心脏病学 心脏病学
- 实施科学 实施科学
- 老年病的医生 老年病的医生
背景情况:
- 心血管疾病 (CVD) 患者中脆弱性很普遍.
- 虚弱与心血管疾病的健康状况不佳有关.
研究的目的:
- 突出实施科学在管理心血管疾病脆弱性的作用.
- 倡导将实施研究纳入心血管疾病试验.
- 改善脆弱性干预措施的采用和常规使用.
主要方法:
- 对实施的障碍和促进者的分析.
- 探索用于指导实施的概念框架.
- 为支持长期实施的试验设计提出建议.
主要成果:
- 实施科学提供了克服脆弱性护理挑战的策略.
- 概念框架有助于结构化和评估实施努力.
- 具体的试验设计可以提高脆弱性干预措施的可持续性.
结论:
- 将实施科学整合到心血管疾病研究中,对于有效的脆弱性管理至关重要.
- 了解实施因素对于将研究转化为实践至关重要.
- 未来的CVD试验应纳入实施策略,以确保持久的影响.
相关概念视频
Heart Failure VII: Nursing Interventions
397
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
397
Heart Failure VI: Adjunct Therapies
235
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
235
Heart Failure V: Medical Management
200
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
200
Heart Failure I: Introduction
670
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
670
Coronary Artery Disease IV: Preventive Measures
575
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
575
Heart Failure II: Pathophysiology
685
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
685


